Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects (Q44625716)

4 December 2017

title

Ex vivo fludarabine exposure inhibits graft-versus-host activity of allogeneic T cells while preserving graft-versus-leukemia effects (English)

1 reference

4 December 2017

1 reference

6

Sagar Lonial

1 reference

4 December 2017

Cynthia R Giver

1

1 reference

4 December 2017

Richard O Montes

2

1 reference

4 December 2017

Stephen Mittelstaedt

3

1 reference

4 December 2017

Jian-Ming Li

4

1 reference

4 December 2017

David L Jaye

5

1 reference

4 December 2017

Michael W Boyer

7

1 reference

4 December 2017

Edmund K Waller

8

1 reference

4 December 2017

publication date

1 October 2003

1 reference

Biology of Blood and Marrow Transplantation

4 December 2017

published in

1 reference

4 December 2017

volume

9

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

616-632

1 reference

New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Purine nucleoside modulation of functions of human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Infectious and immunosuppressive complications of purine analog therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Divided we stand: tracking cell proliferation with carboxyfluorescein diacetate succinimidyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Division rate and phenotypic differences discriminate alloreactive and nonalloreactive T cells transferred in lethally irradiated mice

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Potential and limitations of HSV-TK-transduced donor peripheral blood lymphocytes after allo-BMT

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Analysis of the requirements for the induction of CD4+ T cell alloantigen hyporesponsiveness by ex vivo anti-CD40 ligand antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Bone marrow transplantation across major genetic barriers: the role of megadose stem cells and nonalloreactive donor anti-third party CTLS.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Clinical use of irradiated donor lymphocytes in bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Induction of T helper type 2 immunity by a point mutation in the LAT adaptor

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Lethal host-versus-graft disease and hypereosinophilia in the absence of MHC I-T-cell interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Dichotomy between naïve and memory CD4(+) T cell responses to Fas engagement

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Murine acute graft-versus-host disease can be prevented by depletion of alloreactive T lymphocytes using activation-induced cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Early intestinal Th1 inflammation and mucosal T cell recruitment during acute graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

Graft-versus-host disease in the absence of the spleen after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900229-5

7 January 2021

10.1016/S1083-8791(03)00229-5

Identifiers

DOI

1 reference

4 December 2017

1 reference